Hudson Research

Explore some of our latest findings

Hudson Medical’s clinical team is committed to participating in groundbreaking research across interventional pain management, Long COVID treatment, regenerative medicine, and more.
View a few of our most recent discoveries below:

Botox-Enhanced Stellate Ganglion Blockade for the Treatment of Post-traumatic Stress Disorder

Research Paper

Emerging evidence promotes stellate ganglion blocks (SGB) as a treatment for post-traumatic stress disorder (PTSD) in individuals who have not fully responded to conventional therapies. Ongoing research aims to assess the reliability and sustainability of this intervention.

Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID

Clinical Study

The main purpose of this study is to gather data and assess changes in patient-reported outcomes with the stellate ganglion blocks as treatment for their sympathetically-mediated long COVID symptoms.

Which Long-COVID Treatment is Right for You?

Research Paper

Which Long-COVID Treatment Is Right For You? Read on to learn about the treatments that may help your Long COVID symptoms.

Ingredients and Associated Benefits of Hudson Health's Vitamin IV Therapy Blends

Treatment Summary

Learn more about the ingredients included in our energy, immunity, brain health, and inflammation vitamin IV blends. 

Evidence for Stellate Ganglion Block (SGB) as a Novel Management Strategy for Anxiety Disorders

Research Paper

Stellate Ganglion Blocks (SGB) modulate sympathetic signaling and have been shown to provide significant and long-lasting symptom relief for patients with PTSD and trauma-related anxiety. Assuming GAD and PTSD are in some measure driven by abnormal sympathetic signaling, then SGB may have an impact on GAD symptoms.

Interventional Mental Health as a New Discipline: A Review

Research Paper

We hypothesize that creating unique treatment algorithm combining current therapeutic modalities such as Stellate Ganglion Blocks (SGB), Transcranial Magnetic Stimulation (TMS) therapy, and ketamine therapy, within a consolidated timeframe, will yield synergistic outcomes among patients presenting with comorbid post-traumatic stress disorder (PTSD), depression, and/or anxiety.

Dual Sympathetic Block for Post-Acute COVID-19 Syndrome (PACS)

Research Paper

Post-Acute COVID-19 Syndrome (PACS), commonly known as long-haul COVID or long COVID, is a new disease state characterized by the presence of persistent symptoms that affects patients who have recovered from acute infection by the SARS-CoV-2 virus. Some individuals infected with COVID-19 experience new, returning, or ongoing health problems following acute infection by the SARS-CoV-2 virus

Dual Sympathetic Block for PTSD

Research Paper

Recent neuroscience research has revealed a new therapeutic avenue for individuals with PTSD: Dual Sympathetic Blocks (DSBs). DSBs are a specialized sympathetic nerve block in which local anesthetic is injected into the right cervical sympathetic ganglion during the first appointment and the procedure is repeated on the left cervical sympathetic ganglion during the second appointment, reducing the concern of phrenic and recurrent laryngeal nerve palsy.

EBOO Therapy​

Treatment Summary

Extracorporeal Blood Oxygenation and Ozonation (EBOO) therapy is a medical procedure that involves using specialized equipment to infuse medical-grade ozone gas into a patient’s blood outside of their body. EBOO therapy can be applied in the treatment of chronic pain and inflammation, infections, circulatory disorders, fungal infections, and many other conditions.

GLP-1 Agonists and Mood Disorders​

Treatment Summary

GLP-1 is a peptide hormone produced primarily in intestinal L-cells, as well as in microglia and specific neurons of the nucleus tractus solitarius. GLP-1 is secreted into the blood
(1). GLP-1 production is regulated by blood glucose (blood sugar) levels, so elevated blood glucose levels cause an increase in GLP-1 secretion (1).

Inflammation + Root Health Summary

Treatment Summary

Inflammation occurs when cells of the immune system become activated by the presence of infections or ‘sterile’ agents (physical, chemical or metabolic stimuli released in response to cellular damage or stress) (1). The immune system has a wide response spectrum and can thus execute local and systemic inflammatory responses to eliminate threats.

Regenerative Medicine Injections​

Treatment Summary

At Hudson Medical, we understand the immense potential of Regenerative Medicine and are dedicated to providing you with the most advanced treatment options that target your specific needs. We use minimally-invasive techniques to treat various tissue injuries by stimulating the regeneration of damaged tissue. These regenerative therapies are designed to repair damaged tissues to reduce the need for more invasive procedures.

Safety of bone marrow derived mesenchymal stem cell extracellular vesicle injection for lumbar facet joint pain

Clinical Study

Dr. Kuo co-authored a 2024 pilot study assessing the efficacy of treating lumbar facet joint pain (lower back joint pain) with bone marrow-derived mesenchymal stem cell exosomes. The safety and efficacy results of this pilot were published in Future Medicine’s Regenerative Medicine Journal.

SGB for Long COVID​

Research Paper

Long COVID, formally known as Post-Acute COVID-19 Syndrome (PACS), is a variety of persistent symptoms that affects patients who have recovered from acute infection by the SARS-CoV-2 virus. Some individuals infected with COVID-19 experience new, returning, or ongoing health problems as a result of the SARS-CoV-2 virus. 

Reimagined healthcare, designed for you.

Experience the power of patient-centered healthcare.